)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Nanoform Finland
Nanoform Finland (NANOFH) investor relations material
Nanoform Finland Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary26 Feb, 2026
Executive summary
Launched breakthrough strategies for both small and large molecules, leveraging proprietary CESS® and BioLine technologies to enable a shift from IV to subcutaneous delivery in biologics, with a goal of three nanoformed medicines and >50% CAGR with EBIT margin >30% by 2030.
Achieved significant milestones: new IP, industrial-scale readiness, GMP batches for key products, commercial deals in five countries, and expansion into Asia.
Major US pharma partnership, new patent granted in the USA, and commercial cGMP manufacturing license for Europe.
Revenue increased 28% year-over-year to EUR 3.5 million, driven by 53 customer projects and improved gross margin to 86% from 80%.
Workforce reduced by 6% to 171 employees, with further cost-saving measures announced for 2026.
Financial highlights
Record revenue and other operating income in 2025, with first-time income from associated companies and Q4 revenue up 79% year-over-year to EUR 1.3 million.
EBITDA improved year-over-year, with loss narrowed to EUR -15.2 million from EUR -21.0 million, and operating loss at EUR -18.5 million.
Cash position at year-end was EUR 24.0 million, providing a comfortable runway.
Cost reductions and change negotiations expected to lower annual cash burn by EUR 5–6 million.
Full-year gross profit rose to EUR 3.0 million, with total operating costs down 9% to EUR 22.6 million.
Outlook and guidance
Targets for 2026 include cash burn below EUR 10 million, first marketing authorization application for a nanoformed medicine, and increased project signings.
Mid-term goals for 2030: launch three nanoformed medicines, achieve >50% CAGR income growth (2026–30), and EBIT margin above 30%.
Strategic planning underway for commercial launch of Nanoenzalutamide in Europe by 2028.
Milestone payments from new and existing kernels could further improve cash flow.
Nanoenzalutamide: adjusted regulatory strategy
Biologics: hyaluronidase-free SC delivery impact
How do 2026 cost savings ensure cash burn target?
Biologics: Capitalize on market alternatives
Product kernels: Strategy for new commercial models
BioLine: Partnering strategy for GMP readiness
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Nanoform Finland earnings date
Q1 202619 May, 2026
Nanoform Finland
Next Nanoform Finland earnings date
Q1 202619 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Nanoform provides nanotechnology and drug particle engineering services for the pharmaceutical industry. The company offers nanoparticle milling, a mechanical fragmentation process that reduces the particle size of APIs and enables the development of more bioavailable formulations. In addition, it provides physical characterization services for nanoparticles that comprises morphological analysis, including atomic force microscopy and scanning electron microscopy; elemental chemical analysis comprising inductively coupled plasma optical emission spectroscopy; and particle size distribution analysis comprising dynamic light scattering and laser diffraction, as well as supporting analytical equipment. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage